Jörg Haisser

Title: Jörg Haisser: Innovator in Ophthalmic Treatments

Introduction

Jörg Haisser is a notable inventor based in Siegelsbach, Germany. He has made significant contributions to the field of ophthalmology, particularly in the treatment of uveitis. His innovative approach has led to the development of a unique pharmaceutical composition that addresses this challenging condition.

Latest Patents

Haisser holds a patent for an ophthalmic composition specifically designed for the treatment of uveitis. This invention provides pharmaceutical compositions comprising cyclosporine dissolved in a semifluorinated alkane. This formulation aims to enhance the effectiveness of treatment for patients suffering from uveitis.

Career Highlights

Jörg Haisser is associated with Novaliq GmbH, a company dedicated to advancing ophthalmic therapies. His work at Novaliq has positioned him as a key player in the development of innovative solutions for eye care. With a focus on improving patient outcomes, Haisser continues to push the boundaries of what is possible in ophthalmic treatments.

Collaborations

Haisser collaborates with talented professionals in his field, including Frank Löscher and Chiara Silvana Leo. These partnerships enhance the research and development efforts at Novaliq, fostering an environment of innovation and creativity.

Conclusion

Jörg Haisser's contributions to ophthalmology through his patent and work at Novaliq GmbH highlight his commitment to improving treatments for uveitis. His innovative spirit and collaborative efforts continue to make a significant impact in the field.